+Search query
-Structure paper
Title | Discovery of DS-9300: A Highly Potent, Selective, and Once-Daily Oral EP300/CBP Histone Acetyltransferase Inhibitor. |
---|---|
Journal, issue, pages | J. Med. Chem., Vol. 66, Page 695-715, Year 2023 |
Publish date | Sep 26, 2022 (structure data deposition date) |
Authors | Kanada, R. / Kagoshima, Y. / Suzuki, T. / Nakamura, A. / Funami, H. / Watanabe, J. / Asano, M. / Takahashi, M. / Ubukata, O. / Suzuki, K. ...Kanada, R. / Kagoshima, Y. / Suzuki, T. / Nakamura, A. / Funami, H. / Watanabe, J. / Asano, M. / Takahashi, M. / Ubukata, O. / Suzuki, K. / Aikawa, T. / Sato, K. / Goto, M. / Setsu, G. / Ito, K. / Kihara, K. / Kuroha, M. / Kohno, T. / Ogiwara, H. / Isoyama, T. / Tominaga, Y. / Higuchi, S. / Naito, H. |
External links | J. Med. Chem. / PubMed:36572866 |
Methods | X-ray diffraction |
Resolution | 2 Å |
Structure data | PDB-8gzc: |
Chemicals | ChemComp-ZN: ChemComp-KQO: ChemComp-HOH: |
Source |
|
Keywords | TRANSFERASE / epigenetics / SBDD / Histone acetyltransferase |